# GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

> **NCT07127172** · NA · RECRUITING · sponsor: **Neuralink Corp** · enrollment: 7 (estimated)

## Conditions studied

- Tetraplegia/Tetraparesis
- Quadriplegia
- Quadriplegia/Tetraplegia
- Cervical Spinal Cord Injury
- Amyotrophic Lateral Sclerosis (ALS)
- Spinal Cord Injury (Quadraplegia)
- Spinal Cord Injury
- Motor Neuron Disease
- Brain Stem Stroke

## Interventions

- **DEVICE:** N1 Implant
- **DEVICE:** R1 Robot

## Key facts

- **NCT ID:** NCT07127172
- **Lead sponsor:** Neuralink Corp
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2028-01
- **Final completion:** 2031-02
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2025-08-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07127172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07127172, "GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07127172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*